Browsing: Wellness Tips

Rising blood sugar levels, leading to progressive exhaustion of the pancreas and reduced effectiveness of insulin. Almost constant inflammation, affecting organ health and blood circulation. Metabolic disturbances that tend to worsen cholesterol and blood lipid levels, as well as increasing the risk of developing diabetes. A direct route to high blood pressure. A tape measure…

The weight loss market continues to boom, with patients constantly looking for more powerful GLP-1s, cheaper versions, and new ways to take them

detail *It has been translated using AI As Hanmi Pharmaceutical has achieved the feat of exporting up to $2.3 billion (about 3.1723 trillion won) worth of new obesity drug candidates to Genentech, a subsidiary of Global Big Pharma Roche, attention is being paid to the obesity treatment pipeline of domestic pharmaceutical and bio companies aiming…

Benchmarks Nifty24,279.9027.91 FEATURED FUNDS★★★★★ Motilal Oswal Midcap Fund Direct-Growth 5Y Return 24.08 % Invest Now Enter search text:

HM17321 3.2 Technology Export to Genentech Proof of Global Competitiveness of Obesity ProjectLabs Recovery-based New Drug Development is also re-examined Lim Joo-hyun, vice chairman of Hanmi Pharmaceutical. [HANMI Pharmaceutical Co., Ltd.]

Now ‘quality’ competition rather than weight lossFood intake is maintained, but weight loss is lost by increasing energy consumption “Please draw an image of losing weight by eating a lot and exercising.” An image created by AI. [Gemini]

Hanmi Pharm, a Korean pharmaceutical company, said Monday it has signed a 3.2 trillion-won ($2.3 billion) licensing deal with Genentech, a U.S.-based member of the Roche Group, for an obesity drug candidate designed to reduce body fat while preserving and increasing muscle mass

The number of illegally imported obesity treatment drugs detected surged in the first half of this year, driven largely by drugs ordered from foreign websites and shipped through international mail

Unauthorized imports of weight-loss medications into South Korea surged in the first half of this year, reaching 3.5 times the total recorded throughout 2025, according to the Korea Customs Service on Monday

More than 4,000 cases of illegal imports of the obesity drugs Wegovy and Mounjaro were detected in Korea in the first half of this year, 3.5 times the number recorded for all of last year